{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:59:01Z","timestamp":1793465941334,"version":"4.5.0"},"reference-count":79,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.5551\/jat.rv22042","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:07:29Z","timestamp":1756937249000},"page":"1359-1367","source":"Crossref","is-referenced-by-count":14,"title":["Beyond High-density Lipoprotein-cholesterol: Unraveling the Complexity of High-density Lipoprotein Functionality"],"prefix":"10.5551","volume":"32","author":[{"given":"Yasuhiro","family":"Endo","sequence":"first","affiliation":[{"name":"Division of laboratory Medicine, Faculty of Medicine, Tohoku medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Medical Education and Research, Japan Self-defense Force Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[{"name":"Center for Preventive Medicine, The Jikei University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH: The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res, 2009; 50 Suppl: S189-194","DOI":"10.1194\/jlr.R800088-JLR200"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Glomset JA, Janssen ET, Kennedy R, Dobbins J: Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. J Lipid Res, 1966; 7: 638-648","DOI":"10.1016\/S0022-2275(20)39245-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wilson PW, Abbott RD, Castelli WP: High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis, 1988; 8: 737-741","DOI":"10.1161\/01.ATV.8.6.737"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Madsen CM, Varbo A, Nordestgaard BG: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J, 2017; 38: 2478-2486","DOI":"10.1093\/eurheartj\/ehx163"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M, Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T: Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol, 2018; 12: 674-684.e675","DOI":"10.1016\/j.jacl.2018.01.014"},{"key":"6","unstructured":"6) Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, DerOhannessian S, Kontush A, Surendran P, Saleheen D, Trompet S, Jukema JW, De Craen A, Deloukas P, Sattar N, Ford I, Packard C, Majumder A, Alam DS, Di Angelantonio E, Abecasis G, Chowdhury R, Erdmann J, Nordestgaard BG, Nielsen SF, Tybj\u00e6rg-Hansen A, Schmidt RF, Kuulasmaa K, Liu DJ, Perola M, Blankenberg S, Salomaa V, M\u00e4nnist\u00f6 S, Amouyel P, Arveiler D, Ferrieres J, M\u00fcller-Nurasyid M, Ferrario M, Kee F, Willer CJ, Samani N, Schunkert H, Butterworth AS, Howson JM, Peloso GM, Stitziel NO, Danesh J, Kathiresan S, Rader DJ: Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science, 2016; 351: 1166-1171"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tall AR, Rader DJ: Trials and Tribulations of CETP Inhibitors. Circ Res, 2018; 122: 106-112","DOI":"10.1161\/CIRCRESAHA.117.311978"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sarraju A, Brennan D, Hayden K, Stronczek A, Goldberg AC, Michos ED, McGuire DK, Mason D, Tercek G, Nicholls SJ, Kling D, Neild AL, Kastelein J, Davidson M, Ditmarsch M, Nissen SE: Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet, 2025; 405: 1757-1768","DOI":"10.1016\/S0140-6736(25)00721-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ: Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med, 2011; 364: 127-135","DOI":"10.1056\/NEJMoa1001689"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shimizu T, Miyazaki O, Iwamoto T, Usui T, Sato R, Hiraishi C, Yoshida H: A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol. J Lipid Res, 2019; 60: 1959-1967","DOI":"10.1194\/jlr.D086884"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sankaranarayanan S, Kellner-Weibel G, de la Llera-Moya M, Phillips MC, Asztalos BF, Bittman R, Rothblat GH: A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol. J Lipid Res, 2011; 52: 2332-2340","DOI":"10.1194\/jlr.D018051"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sato M, Neufeld EB, Playford MP, Lei Y, Sorokin AV, Aponte AM, Freeman LA, Gordon SM, Dey AK, Jeiran K, Hamasaki M, Sampson ML, Shamburek RD, Tang J, Chen MY, Kotani K, Anderson JL, Dullaart RP, Mehta NN, Tietge UJ, Remaley AT: Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. J Clin Invest, 2023; 133","DOI":"10.1172\/JCI165370"},{"key":"13","unstructured":"13) Sato M, Hamasaki M, Neufeld EB, Remaley AT, Kotani K: Communication: High-Density Lipoprotein-Specific Phospholipid Efflux in Familial Hypercholesterolemia. Ann Clin Lab Sci, 2024; 54: 419-422"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Libby P: The changing landscape of atherosclerosis. Nature, 2021; 592: 524-533","DOI":"10.1038\/s41586-021-03392-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Matsuura Y, Kanter JE, Bornfeldt KE: Highlighting Residual Atherosclerotic Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol, 2019; 39: e1-e9","DOI":"10.1161\/ATVBAHA.118.311999"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ: Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest, 2007; 117: 2216-2224","DOI":"10.1172\/JCI32057"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW: HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med, 2014; 371: 2383-2393","DOI":"10.1056\/NEJMoa1409065"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ishikawa T, Ayaori M, Uto-Kondo H, Nakajima T, Mutoh M, Ikewaki K: High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease. Atherosclerosis, 2015; 242: 318-322","DOI":"10.1016\/j.atherosclerosis.2015.06.028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ogura M, Hori M, Harada-Shiba M: Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2016; 36: 181-188","DOI":"10.1161\/ATVBAHA.115.306665"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Papagiannis A, Gkolfinopoulou C, Tziomalos K, Dedemadi AG, Polychronopoulos G, Milonas D, Savopoulos C, Hatzitolios AI, Chroni A: HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke and predict its outcome. Clin Chim Acta, 2023; 540: 117229","DOI":"10.1016\/j.cca.2023.117229"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chindhy S, Joshi P, Khera A, Ayers CR, Hedayati SS, Rohatgi A: Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events. J Am Coll Cardiol, 2018; 72: 698-700","DOI":"10.1016\/j.jacc.2018.05.043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) He Y, Ronsein GE, Tang C, Jarvik GP, Davidson WS, Kothari V, Song HD, Segrest JP, Bornfeldt KE, Heinecke JW: Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles. Circ Res, 2020; 127: 1198-1210","DOI":"10.1161\/CIRCRESAHA.120.317178"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liao KP, Playford MP, Frits M, Coblyn JS, Iannaccone C, Weinblatt ME, Shadick NS, Mehta NN: The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. J Am Heart Assoc, 2015; 4","DOI":"10.1161\/JAHA.114.001588"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Endo Y, Teramoto M, Arakawa J, Ukita S, Toshima G, Suenaga Y, Sasaki K, Ayaori M, Nakayama H, Inoue Y, Ikewaki K: Obstructive sleep apnea syndrome attenuated high-density lipoprotein function. J Clin Lipidol, 2024; 18: e1035-e1045","DOI":"10.1016\/j.jacl.2024.05.008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kopecky C, Ebtehaj S, Genser B, Drechsler C, Krane V, Antlanger M, Kovarik JJ, Kaltenecker CC, Parvizi M, Wanner C, Weichhart T, S\u00e4emann MD, Tietge UJ: HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients. J Am Soc Nephrol, 2017; 28: 769-775","DOI":"10.1681\/ASN.2016030262"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A, 2000; 97: 12097-12102","DOI":"10.1073\/pnas.200367697"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yasuda T, Grillot D, Billheimer JT, Briand F, Delerive P, Huet S, Rader DJ: Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol, 2010; 30: 781-786","DOI":"10.1161\/ATVBAHA.109.195693"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zanotti I, Pot\u00ec F, Pedrelli M, Favari E, Moleri E, Franceschini G, Calabresi L, Bernini F: The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential. J Lipid Res, 2008; 49: 954-960","DOI":"10.1194\/jlr.M700254-JLR200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Calpe-Berdiel L, Rotllan N, Fi\u00e9vet C, Roig R, Blanco-Vaca F, Escol\u00e0-Gil JC: Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5\/G8. J Lipid Res, 2008; 49: 1904-1911","DOI":"10.1194\/jlr.M700470-JLR200"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nishida T, Ayaori M, Arakawa J, Suenaga Y, Shiotani K, Uto-Kondo H, Komatsu T, Nakaya K, Endo Y, Sasaki M, Ikewaki K: Liver-specific Lxr inhibition represses reverse cholesterol transport in cholesterol-fed mice. Atherosclerosis, 2024; 397: 117578","DOI":"10.1016\/j.atherosclerosis.2024.117578"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P: A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell, 2001; 7: 161-171","DOI":"10.1016\/S1097-2765(01)00164-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B: PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med, 2001; 7: 53-58","DOI":"10.1038\/83348"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science, 1999; 284: 1362-1365","DOI":"10.1126\/science.284.5418.1362"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science, 2000; 289: 1524-1529","DOI":"10.1126\/science.289.5484.1524"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Xu Y, Li F, Zalzala M, Xu J, Gonzalez FJ, Adorini L, Lee YK, Yin L, Zhang Y: Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology, 2016; 64: 1072-1085","DOI":"10.1002\/hep.28712"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Shimizu T, Miyoshi M, Kakinuma S, Tsuchiya J, Yamane D, Watakabe K, Mochida T, Inada K, Yamada K, Shinozaki K, Sato A, Kaneko S, Kawai-Kitahata F, Murakawa M, Nitta S, Nakagawa M, Watanabe M, Asahina Y, Okamoto R: Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids. Cell Rep, 2025; 44: 115675","DOI":"10.1016\/j.celrep.2025.115675"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Zhang Y, Jing Y, He J, Dong R, Li T, Li F, Zheng X, Liu G, Jia R, Xu J, Wu F, Jia C, Song J, Zhang L, Zhou P, Wang H, Yao Z, Liu Q, Yu Y, Zhou J: Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis. Immunity, 2025; 58: 683-700.e610","DOI":"10.1016\/j.immuni.2025.02.003"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ: Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest, 2011; 121: 2921-2931","DOI":"10.1172\/JCI57275"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ram\u00edrez CM, Rotllan N, Vlassov AV, D\u00e1valos A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno A, Wanschel A, Zavadil J, Castrillo A, Kim J, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C: Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res, 2013; 112: 1592-1601","DOI":"10.1161\/CIRCRESAHA.112.300626"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Uto-Kondo H, Ayaori M, Sotherden GM, Nakaya K, Sasaki M, Yogo M, Komatsu T, Takiguchi S, Yakushiji E, Ogura M, Nishida T, Endo Y, Ikewaki K: Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway. Biochim Biophys Acta, 2014; 1841: 1247-1255","DOI":"10.1016\/j.bbalip.2014.05.009"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Yakushiji E, Ayaori M, Nishida T, Shiotani K, Takiguchi S, Nakaya K, Uto-Kondo H, Ogura M, Sasaki M, Yogo M, Komatsu T, Lu R, Yokoyama S, Ikewaki K: Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice. Arterioscler Thromb Vasc Biol, 2016; 36: 591-597","DOI":"10.1161\/ATVBAHA.115.306376"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Takiguchi S, Ayaori M, Yakushiji E, Nishida T, Nakaya K, Sasaki M, Iizuka M, Uto-Kondo H, Terao Y, Yogo M, Komatsu T, Ogura M, Ikewaki K: Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I\/ATP-Binding Cassette Transporter A1-Dependent Pathways. Arterioscler Thromb Vasc Biol, 2018; 38: 1454-1467","DOI":"10.1161\/ATVBAHA.118.311056"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Brown RJ, Lagor WR, Sankaranaravanan S, Yasuda T, Quertermous T, Rothblat GH, Rader DJ: Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ Res, 2010; 107: 357-364","DOI":"10.1161\/CIRCRESAHA.110.219188"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Bell TA, 3rd, Liu M, Donner AJ, Lee RG, Mullick AE, Crooke RM: Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice. J Lipid Res, 2021; 62: 100101","DOI":"10.1016\/j.jlr.2021.100101"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Sandhu J, Li S, Fairall L, Pfisterer SG, Gurnett JE, Xiao X, Weston TA, Vashi D, Ferrari A, Orozco JL, Hartman CL, Strugatsky D, Lee SD, He C, Hong C, Jiang H, Bentolila LA, Gatta AT, Levine TP, Ferng A, Lee R, Ford DA, Young SG, Ikonen E, Schwabe JWR, Tontonoz P: Aster Proteins Facilitate Nonvesicular Plasma Membrane to ER Cholesterol Transport in Mammalian Cells. Cell, 2018; 175: 514-529.e520","DOI":"10.1016\/j.cell.2018.08.033"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 1994; 24: 1468-1474","DOI":"10.1016\/0735-1097(94)90141-4"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Kimura T, Tomura H, Sato K, Ito M, Matsuoka I, Im DS, Kuwabara A, Mogi C, Itoh H, Kurose H, Murakami M, Okajima F: Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells. J Biol Chem, 2010; 285: 4387-4397","DOI":"10.1074\/jbc.M109.043869"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, Shaul PW: High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med, 2001; 7: 853-857","DOI":"10.1038\/89986"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Nofer JR, van der Giet M, T\u00f6lle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, G\u00f6decke A, Ishii I, Kleuser B, Sch\u00e4fers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest, 2004; 113: 569-581","DOI":"10.1172\/JCI18004"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM: Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem, 2012; 287: 44645-44653","DOI":"10.1074\/jbc.M112.423426"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Matsuo Y, Miura S, Kawamura A, Uehara Y, Rye KA, Saku K: Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis, 2007; 194: 159-168","DOI":"10.1016\/j.atherosclerosis.2006.10.020"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation, 1996; 94: 266-271","DOI":"10.1161\/01.CIR.94.3.266"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Miwa K, Yoshida N, Nakagawa K, Inoue H: High-density lipoprotein particles are large in patients with variant angina. Cardiovasc Res, 1998; 37: 729-737","DOI":"10.1016\/S0008-6363(97)00286-1"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Funayama A, Watanabe T, Tamabuchi T, Otaki Y, Netsu S, Hasegawa H, Honda S, Ishino M, Arimoto T, Takahashi H, Shishido T, Miyamoto T, Nitobe J, Kubota I: Elevated cystatin C levels predict the incidence of vasospastic angina. Circ J, 2011; 75: 2439-2444","DOI":"10.1253\/circj.CJ-11-0008"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Sasaki K, Ezaki H, Endo Y, Kudo D, Suenaga Y, Ayaori M, Sakurada M, Ikewaki K: Roles of HDL function and sphingosine-1-phosphate in vasospastic angina. Clin Chim Acta, 2025; 574: 120338","DOI":"10.1016\/j.cca.2025.120338"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Ridker PM: High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J, 2004; 148: S19-26","DOI":"10.1016\/j.ahj.2004.04.028"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med, 2017; 377: 1119-1131","DOI":"10.1056\/NEJMoa1707914"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, L\u00f3pez-Send\u00f3n J, Ostadal P, Koenig W, Angoulvant D, Gr\u00e9goire JC, Lavoie MA, Dub\u00e9 MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L\u2019Allier PL, Guertin MC, Roubille F: Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med, 2019; 381: 2497-2505","DOI":"10.1056\/NEJMoa1912388"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ: High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol, 1995; 15: 1987-1994","DOI":"10.1161\/01.ATV.15.11.1987"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Jia C, Anderson JLC, Gruppen EG, Lei Y, Bakker SJL, Dullaart RPF, Tietge UJF: High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events. Circulation, 2021; 143: 1935-1945","DOI":"10.1161\/CIRCULATIONAHA.120.050808"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Keul P, Polzin A, Kaiser K, Gr\u00e4ler M, Dannenberg L, Daum G, Heusch G, Levkau B: Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy. Faseb j, 2019; 33: 1482-1495","DOI":"10.1096\/fj.201801245R"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Tanaka S, Couret D, Tran-Dinh A, Duranteau J, Montravers P, Schwendeman A, Meilhac O: High-density lipoproteins during sepsis: from bench to bedside. Crit Care, 2020; 24: 134","DOI":"10.1186\/s13054-020-02860-3"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold KR: Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res, 1999; 40: 245-252","DOI":"10.1016\/S0022-2275(20)33363-0"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Guo L, Morin EE, Yu M, Mei L, Fawaz MV, Wang Q, Yuan Y, Zhan CG, Standiford TJ, Schwendeman A, Li XA: Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice. Sci Signal, 2022; 15: eabl9322","DOI":"10.1126\/scisignal.abl9322"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, R\u00f6cken M, L\u00fctjohann D, Wright SD, Schultze JL, Latz E: High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol, 2014; 15: 152-160","DOI":"10.1038\/ni.2784"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Bonacina F, Pirillo A, Catapano AL, Norata GD: Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL. Curr Opin Lipidol, 2019; 30: 462-469","DOI":"10.1097\/MOL.0000000000000642"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) van der Vorst EPC, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, Aliyev T, Huitema LFA, Tas SW, Wolfs IMJ, Kuijpers MJE, Gijbels MJ, Schalkwijk CG, Koonen DPY, Abdollahi-Roodsaz S, McDaniels K, Wang CC, Leitges M, Lawrence T, Plat J, Van Eck M, Rye KA, Touqui L, de Winther MPJ, Biessen EAL, Donners M: High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-\u03baB\/STAT1-IRF1 Signaling. Cell Metab, 2017; 25: 197-207","DOI":"10.1016\/j.cmet.2016.10.013"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Fotakis P, Kothari V, Thomas DG, Westerterp M, Molusky MM, Altin E, Abramowicz S, Wang N, He Y, Heinecke JW, Bornfeldt KE, Tall AR: Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques. Arterioscler Thromb Vasc Biol, 2019; 39: e253-e272","DOI":"10.1161\/ATVBAHA.119.313253"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Tiniakou I, Drakos E, Sinatkas V, Van Eck M, Zannis VI, Boumpas D, Verginis P, Kardassis D: High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function. J Immunol, 2015; 194: 4676-4687","DOI":"10.4049\/jimmunol.1402870"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Atehortua L, Morris J, Street SE, Bedel N, Davidson WS, Chougnet CA: Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes. J Lipid Res, 2023; 64: 100425","DOI":"10.1016\/j.jlr.2023.100425"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Sorci-Thomas MG, Thomas MJ: High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arterioscler Thromb Vasc Biol, 2012; 32: 2561-2565","DOI":"10.1161\/ATVBAHA.112.300135"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Gupta N, Wollscheid B, Watts JD, Scheer B, Aebersold R, DeFranco AL: Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol, 2006; 7: 625-633","DOI":"10.1038\/ni1337"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Ding BS, Liu CH, Sun Y, Chen Y, Swendeman SL, Jung B, Chavez D, Cao Z, Christoffersen C, Nielsen LB, Schwab SR, Rafii S, Hla T: HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P(1)) promotes regeneration and suppresses fibrosis in the liver. JCI Insight, 2016; 1: e87058","DOI":"10.1172\/jci.insight.87058"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Spillmann F, Miteva K, Pieske B, Tsch\u00f6pe C, Van Linthout S: High-density lipoproteins reduce endothelial-to-mesenchymal transition. Arterioscler Thromb Vasc Biol, 2015; 35: 1774-1777","DOI":"10.1161\/ATVBAHA.115.305887"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Spillmann F, De Geest B, Muthuramu I, Amin R, Miteva K, Pieske B, Tsch\u00f6pe C, Van Linthout S: Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob\/ob mice. J Inflamm (Lond), 2016; 13: 25","DOI":"10.1186\/s12950-016-0131-6"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N: Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med, 2013; 19: 586-594","DOI":"10.1038\/nm.3150"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Jones WL, Ramos CR, Banerjee A, Moore EE, Hansen KC, Coleman JR, Kelher M, Neeves KB, Silliman CC, Di Paola J, Branchford B: Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength. Platelets, 2022; 33: 1119-1131","DOI":"10.1080\/09537104.2022.2078488"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Barlage S, Boettcher D, Boettcher A, Dada A, Schmitz G: High density lipoprotein modulates platelet function. Cytometry A, 2006; 69: 196-199","DOI":"10.1002\/cyto.a.20214"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Turri M, Marchi C, Adorni MP, Calabresi L, Zimetti F: Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders. Biochim Biophys Acta Mol Cell Biol Lipids, 2022; 1867: 159123","DOI":"10.1016\/j.bbalip.2022.159123"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/11\/32_RV22042\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:17:40Z","timestamp":1761970660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/11\/32_RV22042\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22042","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"RV22042"}}